2022 - Research.com Medicine in France Leader Award
His primary areas of study are Pulmonary hypertension, Internal medicine, Surgery, Cardiology and Respiratory disease. His work carried out in the field of Pulmonary hypertension brings together such families of science as Anesthesia, Pathology, Placebo, Vascular resistance and Pulmonary artery. In Vascular resistance, he works on issues like Vascular disease, which are connected to Vein.
His research in Internal medicine tackles topics such as Gastroenterology which are related to areas like Germline mutation. His studies examine the connections between Cardiology and genetics, as well as such issues in Prospective cohort study, with regards to Blood pressure. Gérald Simonneau interconnects Endothelin receptor, Immunology, Intensive care, Intensive care medicine and Pharmacotherapy in the investigation of issues within Respiratory disease.
Gérald Simonneau spends much of his time researching Internal medicine, Pulmonary hypertension, Cardiology, Surgery and Hemodynamics. The various areas that he examines in his Internal medicine study include Gastroenterology and Placebo. His study looks at the relationship between Placebo and topics such as Randomized controlled trial, which overlap with Clinical trial.
His Pulmonary hypertension research focuses on Pulmonary artery and how it relates to Blood pressure and Endocrinology. His work focuses on many connections between Cardiology and other disciplines, such as Bosentan, that overlap with his field of interest in Endothelin receptor antagonist. Many of his studies involve connections with topics such as Associated Pulmonary Arterial Hypertension and Surgery.
Gérald Simonneau focuses on Internal medicine, Pulmonary hypertension, Cardiology, Hemodynamics and Vascular resistance. His work in Internal medicine addresses issues such as Surgery, which are connected to fields such as Young adult. His work deals with themes such as Intensive care medicine, Lung, Pulmonary artery, Pulmonary embolism and Transplantation, which intersect with Pulmonary hypertension.
His work in Hemodynamics covers topics such as Lung transplantation which are related to areas like Vascular remodelling in the embryo. Gérald Simonneau has included themes like Gastroenterology, Cardiac output, Anemia, Retrospective cohort study and Pulmonary wedge pressure in his Vascular resistance study. His Hazard ratio research integrates issues from Survival rate, Tadalafil, Proportional hazards model and Associated Pulmonary Arterial Hypertension.
Internal medicine, Pulmonary hypertension, Cardiology, Vascular resistance and Hemodynamics are his primary areas of study. His Internal medicine research is multidisciplinary, relying on both Placebo and Surgery. His studies in Placebo integrate themes in fields like Clinical trial and Combination therapy.
The study incorporates disciplines such as Young adult and Disease in addition to Surgery. His Pulmonary hypertension research includes themes of Blood pressure, Intensive care medicine, Proportional hazards model, Pulmonary embolism and Macitentan. His work investigates the relationship between Hemodynamics and topics such as Vascular disease that intersect with problems in Pathophysiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
Galiè N;Hoeper Mm;Humbert M;Torbicki A.
European Heart Journal (2009)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Nazzareno Galiè;Marc Humbert;Jean-Luc Vachiery;Simon Gibbs.
European Heart Journal (2016)
Updated Clinical Classification of Pulmonary Hypertension
Gerald Simonneau;Michael A Gatzoulis;Ian Adatia;David Celermajer.
Journal of the American College of Cardiology (2009)
Bosentan therapy for pulmonary arterial hypertension.
Lewis J. Rubin;David B. Badesch;Robyn J. Barst;Nazzareno Galiè.
The New England Journal of Medicine (2002)
Sildenafil citrate therapy for pulmonary arterial hypertension.
Nazzareno Galiè;Hossein A. Ghofrani;Adam Torbicki;Robyn J. Barst.
The New England Journal of Medicine (2005)
Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.
L Brochard;J Mancebo;M Wysocki;F Lofaso.
The New England Journal of Medicine (1995)
Clinical classification of pulmonary hypertension
Gerald Simonneau;Nazzareno Galiè;Lewis J Rubin;David Langleben.
Journal of the American College of Cardiology (2004)
Pulmonary arterial hypertension in France: results from a national registry.
Marc Humbert;Olivier Sitbon;Ari Chaouat;Michèle Bertocchi.
American Journal of Respiratory and Critical Care Medicine (2006)
Inhaled iloprost for severe pulmonary hypertension.
Horst Olschewski;Gerald Simonneau;Nazzareno Galiè;Timothy Higenbottam.
The New England Journal of Medicine (2002)
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
Hervé Decousus;Alain Leizorovicz;Florence Parent;Yves Page.
The New England Journal of Medicine (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: